Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8010063rdf:typepubmed:Citationlld:pubmed
pubmed-article:8010063lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:8010063lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8010063lifeskim:mentionsumls-concept:C0699791lld:lifeskim
pubmed-article:8010063lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:8010063lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:8010063lifeskim:mentionsumls-concept:C0543482lld:lifeskim
pubmed-article:8010063lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8010063pubmed:dateCreated1994-7-20lld:pubmed
pubmed-article:8010063pubmed:abstractTextA fluorouracil (FU)-resistant human carcinoma cell line (SGC-7901/R) was established in culture by progressively increasing the concentration of FU from 50 ng.ml-1 to 2.5 mg.ml-1. The cell line has been successfully subcultured for more than 150 passages during more than 2 years. Its degree of FU resistance was 139-fold vs that of FU sensitive cell line (SGC-7901/S), and the resistant phenotype was stable when cells were cultured for 23 passages in FU-free medium. The doubling time was 17.3 and 25.6 h for resistant cells and parental cells, respectively. Swiss (nu/nu) nude mice were used for the in vivo experiment, the FU-resistant cell line also exhibited resistance to FU and cross-resistance to mitomycin C. FU inhibited markedly the incorporation of [3H]UR into sensitive cells and only showed a 31.6% inhibition with FU 100 micrograms.ml-1 in resistant cells. For the incorporation of [3H]TdR into DNA, inhibitory rates were seen with different concentrations of FU in resistant cells. By morphologic observation, SGC-7901/R cells showed little secretion but without any tendency to glandular pattern. Their nuclei were allotype with enlarged perinuclear space and a few intranuclear pseudoinclusions. The mitotic phase of cells was found frequently. The phenotype of resistant cell line can be deduced more malignant than that of parental cell line.lld:pubmed
pubmed-article:8010063pubmed:languagechilld:pubmed
pubmed-article:8010063pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8010063pubmed:citationSubsetIMlld:pubmed
pubmed-article:8010063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8010063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8010063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8010063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8010063pubmed:statusMEDLINElld:pubmed
pubmed-article:8010063pubmed:monthNovlld:pubmed
pubmed-article:8010063pubmed:issn0253-9756lld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:ChenL JLJlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:LiuM ZMZlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:ZhangS YSYlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:YangW YWYlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:HOUF SFSlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:HanJ XJXlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:XuJ YJYlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:RhoK SKSlld:pubmed
pubmed-article:8010063pubmed:authorpubmed-author:ZhouJ JJJlld:pubmed
pubmed-article:8010063pubmed:issnTypePrintlld:pubmed
pubmed-article:8010063pubmed:volume14 Suppllld:pubmed
pubmed-article:8010063pubmed:ownerNLMlld:pubmed
pubmed-article:8010063pubmed:authorsCompleteYlld:pubmed
pubmed-article:8010063pubmed:paginationS1-4lld:pubmed
pubmed-article:8010063pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:meshHeadingpubmed-meshheading:8010063-...lld:pubmed
pubmed-article:8010063pubmed:year1993lld:pubmed
pubmed-article:8010063pubmed:articleTitle[Characterization of a fluorouracil-resistant human gastric carcinoma cell line and its morphological behavior].lld:pubmed
pubmed-article:8010063pubmed:affiliationShanghai Institute of Materia Medica, Chinese Academy of Sciences.lld:pubmed
pubmed-article:8010063pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8010063pubmed:publicationTypeEnglish Abstractlld:pubmed